Ostatní
Návod 
Puma Biotechnology, Inc.
PBYI
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.2B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
32%
ROA
18%
PE
9
PS
2
Cena 1R
3-6
⌀ Cena
4.37
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda
Profil
Puma Biotechnology, Inc., biofarmaceutická společnost, se zaměřuje na vývoj a komercializaci produktů pro zlepšení léčby rakoviny ve Spojených státech a na mezinárodní úrovni. Mezi lékové kandidáty společnosti patří PB272 neratinib (perorální) pro pacienty s časným stadiem zvýšené exprese HER2/zesíleného karcinomu prsu; PB272 (neratinib, perorální) pro použití neratinibu v kombinaci s kapecitabinem pro léčbu dospělých pacientů s pokročilým nebo metastazujícím HER2 pozitivním karcinomem prsu; PB272 (neratinib, perorální) pro HER2 mutačně pozitivní solidní nádory. Společnost má licenční smlouvu se společností Pfizer, Inc.; a sublicenční smlouvu se společnostmi Specialized Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS a Bixink Therapeutics Co., Ltd. Společnost byla založena v roce 2010 a sídlí v Los Angeles v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
172
Založení
2012-04-24
Podobné společnosti
$ 4.24
+ $ 0.01
$ 3.29
+ $ 0.02
$ 8.65
- $ 0.07
$ 1.19
+ $ 0.01
$ 1.33
- $ 0.00
$ 7.15
+ $ 0.24
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 228.4 | 228.4 | 230.5 | 235.6 | 228.0 | 253.2 | 225.1 | 272.3 | 251.0 | 27.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | 0.0 | |
| Cost of Revenues | 58.2 | 58.2 | 64.4 | 62.7 | 55.1 | 63.7 | 39.4 | 36.8 | 34.6 | 5.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 170.2 | 170.2 | 166.1 | 173.0 | 172.9 | 189.5 | 185.7 | 235.5 | 216.4 | 22.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 75.5 | 54.5 | 52.4 | 46.0 | 59.1 | 80.5 | 47.1 | 43.8 | 72.2 | 56.1 | |
| Cost of Revenues | 23.2 | 12.2 | 12.3 | 10.6 | 13.9 | 29.1 | 10.7 | 10.7 | 24.3 | 13.3 | |
| Gross Profit | 52.3 | 42.3 | 40.1 | 35.5 | 45.2 | 51.4 | 36.4 | 33.0 | 47.9 | 42.8 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 50.4 | 52.2 | 71.9 | 97.7 | 132.9 | 164.9 | 207.8 | 222.8 | 208.5 | 122.9 | 45.0 | 49.6 | 0.8 | 0.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 89.3 | 90.0 | 116.3 | 118.4 | 141.7 | 146.2 | 106.7 | 53.8 | 31.8 | 19.4 | 9.8 | 24.8 | 9.3 | 0.0 | |
| Depreciation & Amortization | 16.6 | 10.9 | 11.5 | 11.5 | 7.8 | 10.6 | 0.9 | 3.0 | 7.4 | 2.8 | 1.1 | 0.8 | 0.6 | 0.4 | 0.3 | 0.0 | 0.0 | |
| Total Operating Expenses | 132.9 | 132.9 | 135.1 | 140.3 | 142.2 | 188.2 | 216.1 | 274.6 | 311.1 | 314.5 | 276.6 | 240.3 | 142.3 | 54.8 | 74.4 | 10.2 | 0.0 | |
| Operating Income | 37.3 | 37.3 | 31.0 | 32.6 | 23.7 | -8.9 | -30.4 | -39.1 | -94.7 | -292.4 | -276.6 | -240.3 | -142.3 | -54.8 | -74.4 | -10.2 | 0.0 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 12.9 | 11.4 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.2 | 22.2 | ||
| Depreciation & Amortization | 8.4 | 2.7 | 2.8 | 2.8 | 2.8 | 2.9 | 2.9 | 2.9 | 2.9 | 2.9 | ||
| Total Operating Expenses | 35.2 | 32.7 | 33.5 | 31.5 | 31.8 | 29.4 | 38.6 | 35.3 | 33.1 | 33.6 | ||
| Operating Income | 17.1 | 9.6 | 6.6 | 4.0 | 13.4 | 22.1 | -2.2 | -2.3 | 14.8 | 8.6 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 4.1 | 4.1 | 4.7 | 2.6 | 0.8 | 0.1 | 0.5 | 2.8 | 1.8 | 1.2 | 1.0 | 1.0 | 0.3 | 0.2 | 0.1 | 0.0 | 0.0 | |
| Interest Expense | 6.6 | 6.6 | 12.5 | 13.3 | 11.5 | 12.8 | 14.1 | 15.0 | 11.0 | 0.7 | 1.0 | 1.0 | 0.3 | 0.2 | 0.1 | 0.0 | 0.0 | |
| Other Expense | -1.5 | -1.5 | -6.9 | -10.0 | -23.2 | -19.9 | -29.4 | -36.5 | -9.7 | -0.1 | -0.4 | 0.0 | 0.0 | 0.0 | 0.1 | -0.1 | 0.0 | |
| IBT | 35.8 | 35.8 | 24.1 | 22.7 | 0.5 | -28.8 | -59.8 | -75.6 | -113.6 | -292.0 | -276.0 | -239.3 | -142.0 | -54.7 | -74.3 | -10.2 | 0.0 | |
| Income Tax Expense | 4.7 | 4.7 | -6.2 | 1.1 | 0.5 | 0.3 | 0.2 | 7.1 | -7.9 | -2.2 | -2.1 | -1.8 | -0.9 | -0.2 | -0.3 | 0.1 | 0.0 | |
| Net Income | 31.1 | 31.1 | 30.3 | 21.6 | 0.9 | -29.1 | -60.0 | -82.7 | -113.6 | -292.0 | -276.0 | -239.3 | -142.0 | -54.7 | -74.3 | -10.2 | 0.0 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 1.0 | 1.0 | 1.0 | 1.1 | 1.2 | 1.3 | 1.2 | 1.0 | 0.7 | 0.7 | ||
| Interest Expense | 1.1 | 1.5 | 1.8 | 2.2 | 2.6 | 3.1 | 3.4 | 3.4 | 3.4 | 3.3 | ||
| Other Expense | 0.0 | -0.3 | -0.5 | -0.7 | -1.1 | -1.5 | -2.0 | -2.3 | -2.0 | -2.6 | ||
| IBT | 17.1 | 9.2 | 6.2 | 3.3 | 12.2 | 20.6 | -4.2 | -4.6 | 12.8 | 6.0 | ||
| Income Tax Expense | 3.7 | 0.4 | 0.3 | 0.3 | -7.1 | 0.3 | 0.4 | 0.2 | 0.5 | 0.2 | ||
| Net Income | 13.4 | 8.8 | 5.9 | 3.0 | 19.3 | 20.3 | -4.5 | -4.8 | 12.3 | 5.8 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.46 | $0.02 | $-0.72 | $-1.52 | $-2.13 | $-2.99 | $-7.86 | $-8.29 | $-7.45 | $-4.73 | $-1.90 | $-3.42 | $-0.51 | $0.00 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.45 | $0.02 | $-0.72 | $-1.52 | $-2.13 | $-2.99 | $-7.86 | $-8.29 | $-7.45 | $-4.73 | $-1.90 | $-3.42 | $-0.51 | $0.00 | |
| Shares Outstanding | 50.3 | 50.0 | 48.6 | 47.1 | 44.7 | 40.6 | 39.6 | 38.8 | 37.9 | 37.2 | 33.3 | 32.1 | 30.0 | 28.7 | 21.7 | 20.0 | 7.7 | |
| Diluted Shares Outstanding | 51.5 | 50.7 | 49.1 | 47.6 | 44.9 | 40.6 | 39.6 | 38.8 | 37.9 | 37.2 | 33.3 | 32.1 | 30.0 | 28.7 | 21.7 | 20.0 | 7.7 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.26 | $0.12 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.26 | $0.12 | ||
| Shares Outstanding | 50.3 | 50.3 | 49.7 | 49.6 | 49.1 | 49.0 | 48.3 | 48.2 | 47.6 | 47.5 | ||
| Diluted Shares Outstanding | 51.5 | 50.9 | 50.1 | 49.9 | 49.4 | 49.2 | 48.3 | 48.2 | 48.0 | 47.8 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 67.1 | 69.2 | 84.6 | 76.2 | 63.1 | 85.3 | 60.0 | 108.4 | 81.7 | 194.5 | 31.6 | 38.5 | 43.0 | 137.4 | 53.4 | 0.0 | |
| Short Term Investments | 29.7 | 31.7 | 11.4 | 4.9 | 19.0 | 8.1 | 51.6 | 57.0 | 0.0 | 35.0 | 184.3 | 102.8 | 40.9 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 96.8 | 101.0 | 95.9 | 76.2 | 63.1 | 85.3 | 60.0 | 108.4 | 81.7 | 194.5 | 31.6 | 38.5 | 83.9 | 137.4 | 53.4 | 0.0 | |
| Accounts Receivable | 28.1 | 32.0 | 48.5 | 42.3 | 32.5 | 25.5 | 28.9 | 21.9 | 9.7 | 0.0 | 0.0 | 1.8 | 9.8 | 10.6 | 0.0 | 0.0 | |
| Inventory | 9.0 | 8.7 | 7.1 | 4.5 | 7.1 | 3.5 | 3.2 | 2.6 | 2.0 | 0.0 | 0.0 | 102.8 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 3.7 | 6.0 | 4.7 | 2.0 | 2.6 | 2.7 | 2.7 | 3.9 | 13.0 | 7.0 | 7.7 | 6.3 | 2.6 | 1.0 | 0.3 | 0.0 | |
| Total Current Assets | 137.7 | 147.7 | 156.2 | 134.3 | 140.0 | 146.1 | 166.3 | 203.0 | 106.4 | 236.5 | 223.5 | 149.4 | 96.4 | 149.0 | 53.7 | 0.0 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 53.5 | 54.7 | 63.0 | 69.2 | 67.3 | 67.1 | 76.8 | 84.6 | 81.8 | 60.0 | |
| Short Term Investments | 40.9 | 41.4 | 30.1 | 31.7 | 29.5 | 29.7 | 30.4 | 11.4 | 3.2 | 14.4 | |
| Total Cash & ST Investments | 94.4 | 96.0 | 93.2 | 101.0 | 96.7 | 96.8 | 107.2 | 95.9 | 85.0 | 74.4 | |
| Accounts Receivable | 33.6 | 25.9 | 25.2 | 32.0 | 54.6 | 28.1 | 24.6 | 48.5 | 29.0 | 31.3 | |
| Inventory | 9.5 | 8.6 | 8.8 | 8.7 | 2.7 | 9.0 | 7.1 | 7.1 | 5.7 | 7.6 | |
| Other Current Assets | 6.2 | 6.1 | 5.4 | 6.0 | 2.8 | 3.7 | 4.2 | 4.7 | 5.7 | 5.2 | |
| Total Current Assets | 143.6 | 136.6 | 132.5 | 147.7 | 156.8 | 137.7 | 143.0 | 156.2 | 125.4 | 118.6 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 6.9 | 5.1 | 8.6 | 12.5 | 15.8 | 18.9 | 21.8 | 4.0 | 4.5 | 5.2 | 2.4 | 2.2 | 1.7 | 1.5 | 0.7 | 0.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 56.0 | 51.1 | 60.9 | 70.6 | 66.1 | 74.1 | 40.5 | 44.4 | 48.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 2.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 2.3 | 2.4 | 4.8 | 4.7 | 4.7 | 5.1 | 6.3 | 6.0 | 6.3 | 11.2 | 13.9 | 11.2 | 6.3 | 1.2 | 1.1 | 0.0 | |
| Total Long-Term Assets | 67.3 | 65.7 | 74.3 | 87.8 | 86.6 | 98.1 | 68.6 | 56.1 | 59.1 | 16.3 | 16.3 | 13.4 | 8.0 | 2.7 | 1.7 | 0.0 | |
| Total Assets | 205.0 | 213.3 | 230.5 | 222.1 | 226.6 | 244.2 | 234.9 | 259.1 | 165.5 | 252.8 | 239.8 | 162.8 | 104.4 | 151.7 | 55.4 | 0.0 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 6.5 | 3.2 | 4.2 | 5.1 | 6.0 | 6.9 | 7.8 | 8.6 | 9.4 | 10.9 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 43.8 | 46.3 | 48.7 | 51.1 | 53.6 | 56.0 | 58.4 | 60.9 | 63.3 | 65.7 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 | 2.1 | 2.1 | 2.1 | 2.6 | 2.6 | |
| Other Long-Term Assets | 9.0 | 1.8 | 3.7 | 2.4 | 2.2 | 2.3 | 2.8 | 2.7 | 5.5 | 5.3 | |
| Total Long-Term Assets | 59.3 | 58.3 | 63.7 | 65.7 | 63.9 | 67.3 | 71.1 | 74.3 | 78.3 | 81.9 | |
| Total Assets | 202.9 | 194.9 | 196.2 | 213.3 | 220.7 | 205.0 | 214.1 | 230.5 | 203.6 | 200.5 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 13.5 | 5.5 | 6.9 | 6.4 | 11.2 | 12.1 | 19.2 | 20.7 | 27.7 | 20.0 | 17.8 | 15.0 | 10.7 | 0.5 | 0.1 | 0.0 | |
| Short-Term Debt | 50.5 | 50.9 | 43.6 | 4.1 | 3.6 | 17.4 | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 40.3 | 39.7 | 48.9 | 66.9 | 2.3 | 2.5 | 69.0 | 46.4 | 30.6 | 17.4 | 14.6 | 29.4 | 8.6 | 21.2 | 0.5 | 0.0 | |
| Current Liabilities | 104.3 | 96.1 | 99.4 | 77.5 | 109.6 | 114.3 | 90.8 | 67.1 | 58.3 | 37.5 | 32.4 | 44.4 | 19.3 | 21.7 | 0.6 | 0.0 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 6.4 | 5.4 | 6.0 | 5.5 | 7.5 | 13.5 | 9.0 | 6.9 | 5.1 | 7.8 | |
| Short-Term Debt | 36.2 | 38.4 | 51.1 | 50.9 | 50.7 | 50.5 | 50.3 | 43.6 | 31.9 | 20.3 | |
| Other Current Liabilities | 40.2 | 35.3 | 29.6 | 39.7 | 52.2 | 40.3 | 38.9 | 48.9 | 30.4 | 32.2 | |
| Current Liabilities | 82.7 | 79.1 | 86.7 | 96.1 | 110.4 | 104.3 | 98.2 | 99.4 | 67.4 | 60.3 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 43.7 | 23.2 | 72.7 | 110.1 | 113.1 | 103.6 | 117.6 | 151.9 | 48.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 4.4 | 7.0 | 11.8 | 16.0 | 19.5 | 22.6 | 25.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 156.5 | 121.2 | 177.1 | 200.5 | 229.0 | 250.2 | 217.4 | 224.8 | 112.2 | 43.0 | 33.8 | 45.7 | 20.4 | 22.8 | 1.0 | 0.0 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 4.9 | 10.9 | 10.6 | 23.2 | 35.7 | 48.1 | 60.4 | 72.7 | 84.9 | 97.1 | |
| Capital Leases | 7.3 | 4.4 | 5.7 | 7.0 | 8.3 | 4.4 | 5.7 | 7.0 | 12.9 | 14.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 87.6 | 90.2 | 99.1 | 121.2 | 149.6 | 156.5 | 163.2 | 177.1 | 164.9 | 170.1 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,354.5 | -1,314.9 | -1,345.2 | -1,366.8 | -1,366.8 | -1,337.6 | -1,277.6 | -1,202.0 | -1,088.5 | -796.5 | -520.5 | -281.2 | -139.3 | -84.6 | -10.2 | -0.1 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | 0.0 | -0.3 | 0.0 | 0.0 | |
| Total Common Equity | 48.5 | 92.1 | 53.4 | 21.6 | -2.4 | -6.0 | 17.5 | 34.3 | 53.3 | 209.8 | 206.0 | 117.0 | 84.0 | 128.9 | 54.4 | 0.0 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,297.2 | -1,306.1 | -1,311.9 | -1,314.9 | -1,334.2 | -1,354.5 | -1,350.0 | -1,345.2 | -1,357.4 | -1,363.2 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 115.3 | 104.7 | 97.1 | 92.1 | 71.1 | 48.5 | 51.0 | 53.4 | 38.7 | 30.4 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 98.6 | 74.1 | 111.5 | 114.3 | 116.6 | 121.0 | 120.2 | 151.9 | 48.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 48.5 | 92.1 | 53.4 | 21.6 | -2.4 | -6.0 | 17.5 | 34.3 | 53.3 | 209.8 | 206.0 | 117.0 | 84.0 | 128.9 | 54.4 | 0.0 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 115.3 | 104.7 | 97.1 | 92.1 | 71.1 | 48.5 | 51.0 | 53.4 | 38.7 | 30.4 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 8.7 | 31.1 | 30.3 | 21.6 | 0.0 | -29.1 | -60.0 | -75.6 | -113.6 | -292.0 | -276.0 | -239.3 | -142.0 | -54.7 | -74.4 | -10.2 | 0.0 | |
| Depreciation & Amortization | 11.6 | 10.9 | 11.5 | 11.5 | 8.9 | 10.6 | 10.0 | 8.1 | 7.4 | 2.8 | 1.1 | 0.8 | 0.6 | 0.4 | 0.3 | 0.0 | 0.0 | |
| Stock-Based Compensation | 9.4 | 6.9 | 8.2 | 10.2 | 11.8 | 32.6 | 36.6 | 57.3 | 86.9 | 108.7 | 117.3 | 94.9 | 39.2 | 7.5 | 1.4 | 0.0 | 0.0 | |
| Change Working Capital | 2.7 | -10.1 | -3.5 | -17.9 | -43.6 | -0.6 | 13.2 | 23.3 | -5.1 | 7.9 | 12.5 | -11.1 | 24.8 | -8.3 | 10.0 | 0.3 | 0.0 | |
| Change In Accounts Receivable | 2.9 | -21.3 | 16.3 | 0.0 | -7.8 | -6.0 | 2.4 | -8.1 | -11.1 | -9.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 5.7 | -0.5 | -1.4 | 0.4 | -4.7 | -0.9 | -7.1 | -1.5 | -7.0 | 7.7 | 2.2 | 2.8 | 4.3 | 10.2 | 0.4 | 0.6 | 0.0 | |
| Change In Inventories | -1.4 | 3.2 | -1.6 | 0.0 | 2.6 | -3.7 | -0.3 | -0.5 | -0.6 | -2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 17.1 | -0.4 | -0.5 | 1.5 | 7.0 | 7.2 | 1.0 | 9.3 | 0.3 | 0.0 | 3.4 | 0.2 | 0.2 | 0.0 | 18.7 | 8.1 | 0.0 | |
| Cash from Operations | 33.3 | 0.0 | 0.0 | 27.0 | -15.8 | 20.7 | 0.8 | 22.4 | -24.1 | -172.5 | -141.7 | -154.5 | -77.2 | -55.0 | -44.0 | -1.8 | 0.0 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 11.8 | 8.8 | 5.9 | 3.0 | 19.3 | 20.3 | -4.5 | -4.8 | 12.3 | 5.8 | |
| Depreciation & Amortization | 8.4 | 2.7 | 2.8 | 2.8 | 2.8 | 2.9 | 2.9 | 2.9 | 2.9 | 2.9 | |
| Stock-Based Compensation | 5.7 | 1.7 | 1.6 | 2.0 | 1.8 | 2.1 | 2.1 | 2.4 | 2.4 | 2.5 | |
| Change Working Capital | -6.5 | -3.3 | 4.2 | -4.4 | -0.8 | -14.2 | 0.8 | 10.7 | -7.5 | -1.2 | |
| Change In Accounts Receivable | -20.1 | -7.4 | -0.4 | 6.6 | 23.0 | -26.5 | -3.3 | 23.1 | -19.2 | 2.3 | |
| Change In Accounts Payable | -1.3 | 1.0 | -0.6 | 0.5 | -2.0 | -6.0 | 4.5 | 2.1 | 1.8 | -2.7 | |
| Change In Inventories | 4.0 | -0.9 | 0.2 | 0.0 | -6.1 | 6.4 | -1.9 | 0.0 | -1.4 | 2.0 | |
| Other Non-cash Items | -4.9 | -0.2 | -0.4 | 0.2 | -0.4 | 0.0 | -0.2 | 0.1 | 27.4 | -1.8 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.5 | 10.6 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.1 | -0.1 | -0.1 | 0.0 | -7.0 | 0.0 | -20.0 | -0.3 | -0.6 | -50.4 | -7.3 | -1.2 | -1.3 | -0.6 | -1.1 | -0.7 | 0.0 | |
| Acquisitions | -3.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -58.2 | -108.1 | -76.2 | -23.8 | -4.8 | -38.1 | -29.8 | -127.2 | -107.5 | -79.7 | -81.8 | -214.8 | -132.3 | -49.3 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 42.9 | 72.0 | 55.8 | 17.3 | 18.9 | 27.2 | 73.3 | 132.7 | 50.5 | 114.7 | 231.3 | 133.2 | 70.3 | 8.4 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | -15.3 | 0.0 | 0.0 | -12.6 | 0.0 | 0.0 | -20.1 | 0.0 | -0.2 | 0.0 | 0.0 | -3.1 | 0.0 | 0.0 | -0.1 | -1.1 | 0.0 | |
| Cash from Investing | -15.4 | 0.0 | 0.0 | -19.1 | 7.1 | -10.9 | 23.3 | 5.2 | -57.6 | -15.4 | 142.2 | -85.9 | -63.3 | -41.5 | -1.2 | -1.7 | 0.0 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.1 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.1 | -11.2 | |
| Investments | -46.9 | -26.8 | -21.9 | -12.5 | -15.3 | -16.1 | -19.9 | -25.0 | -11.3 | -2.0 | |
| Sales of Investment | 38.9 | 27.3 | 10.7 | 14.1 | 13.0 | 16.3 | 20.6 | 5.9 | 3.2 | 13.2 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -8.1 | 11.2 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -8.2 | 11.2 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -11.1 | 0.0 | 0.0 | 0.0 | 0.0 | -100.0 | -8.4 | -80.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | -3.2 | 74.1 | -37.4 | -2.8 | -2.4 | 95.7 | 9.2 | 48.3 | 103.4 | 48.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 12.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 161.9 | 205.1 | 129.4 | 0.0 | 129.2 | 56.9 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -0.2 | 0.0 | 0.0 | 0.0 | -0.3 | 68.1 | 8.5 | 12.9 | 108.4 | 75.1 | 0.5 | 28.3 | 6.6 | 2.2 | 0.1 | 0.1 | 0.0 | |
| Cash from Financing | -11.3 | 0.0 | 0.0 | 0.0 | 12.2 | -31.9 | 0.1 | -67.1 | 108.4 | 75.1 | 162.4 | 233.4 | 136.0 | 2.2 | 129.3 | 57.0 | 0.0 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 41.1 | -8.2 | -12.5 | -12.4 | -12.3 | -12.2 | -12.1 | -0.8 | -0.7 | -0.7 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 7.1 | -39.6 | -15.4 | 7.9 | 3.5 | -22.2 | 24.2 | -39.5 | 26.7 | -112.8 | 162.9 | -7.0 | -4.5 | -94.4 | 84.0 | 57.0 | 0.0 | |
| Closing Cash Balance | 67.1 | 31.7 | 71.3 | 86.7 | 78.8 | 75.3 | 97.5 | 73.2 | 112.7 | 81.7 | 194.5 | 31.6 | 38.5 | 43.0 | 137.4 | 53.4 | 0.0 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -23.9 | -1.1 | -8.4 | -6.2 | 2.0 | 0.1 | -9.6 | -7.8 | 2.8 | 21.8 | |
| Closing Cash Balance | 31.7 | 55.6 | 56.8 | 65.1 | 71.3 | 69.4 | 67.1 | 76.8 | 84.6 | 84.4 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 33.3 | 41.7 | 38.9 | 14.4 | -22.8 | 20.7 | -19.2 | 22.1 | -24.7 | -222.9 | -149.0 | -155.7 | -78.5 | -55.7 | -45.1 | -2.5 | 0.0 | |
| Real Free Cash Flow | 23.8 | 34.8 | 30.6 | 4.1 | -34.6 | -11.9 | -55.8 | -35.2 | -111.6 | -331.7 | -266.2 | -250.6 | -117.6 | -63.2 | -46.5 | -2.5 | 0.0 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 14.5 | 9.7 | 14.1 | 3.6 | 15.6 | 11.0 | 1.0 | 11.2 | 10.4 | 10.6 | |
| Real Free Cash Flow | 8.8 | 8.0 | 12.4 | 1.5 | 13.8 | 9.0 | -1.1 | 8.9 | 8.0 | 8.0 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 9.4 | 450.3 | -1.4 |
| P/S | 1.6 | -8.2 | 9.4 |
| P/B | 3 | -4 | 5.2 |
| P/FCF | 9.7 | -11.8 | -1.5 |
| Market cap | $0.2 | $1.5 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 20.2 % | 32.1 % | 0 % |
| Debt to Income | 132.1 % | 23044.2 % | 0 % |
| Debt to Free cash flow | 133.6 % | -31.8 % | 0 % |
| Interest expense percentage | 17.7 % | 23.1 % | 44.7 % |
| Current ratio | 1.7 | 4.5 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 27 % | -125.6 % | 0 % |
| ROA | 15.3 % | -475.2 % | 0 % |
| CapEx to Revenue | 0.1 % | -10.3 % | 0 % |
| RaD to Revenue | 0 % | -342.8 % | 0 % |
| ROEM | 1,328,011.6 | 423622.8 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 76.9 % | 47.3 % | 68.7 % |
| Operating margin | 15.8 % | 649.3 % | 35.5 % |
| Net margin | 17.4 % | 646.9 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 50.9 mil | 33.4 mil |
| Employee count | 0.2 tis | 0.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
